Iqbavir

Iqbavir 250mg Injection is an antiviral medicine effective against herpes simplex and varicella zoster viruses. It does not cure infections caused by these viruses but helps to minimize the symptoms and shorten the duration of infection. It does not remove the viruses from the body but prevents the viruses from dividing and spreading.

Iqbavir 250mg Injection should be administered under the supervision of a trained healthcare professional or a doctor only and should not be self-administered. It is given by slow intravenous (I.V) infusion over a one hour period to avoid damage to kidneys. The dose will depend on the condition you are being treated for and will be decided by your doctor. Follow your doctor’s instructions carefully to get maximum benefit from Iqbavir 250mg Injection.

No, you can infect other people, even while you are being treated with Iqbavir 250mg Injection. Herpes infections are contagious, so avoid letting infected areas come into contact with other people. Avoid touching your eyes after touching an infected area. Wash your hands frequently to prevent transmitting the infection to others. You should practice safe sex by using condoms. You should not have sex if you have genital sores or blisters.

Serious side effects are rare, but if you experience them, you should seek medical advice right away. These rare side effects include hives, blistering or peeling rash, yellow skin or eyes, unusual bruising or bleeding, loss of consciousness, fits, difficulty in breathing, hallucinations and swelling of the face, tongue, lips or throat.

Older adults (over age 65 years) tend to experience more side effects when taking Iqbavir 250mg Injection. The reason being, their kidneys do not flush the drug out of their system as quickly as a younger person’s kidneys would do. Elderly patients should drink plenty of water while taking Iqbavir 250mg Injection, and their kidney function should be monitored. These patients should be given a lower dose and should be monitored for neurological problems.

Accidental, repeated overdoses of oral Iqbavir 250mg Injection over several days have resulted in nausea, vomiting, confusion and headache. Consult your doctor in case of overdose.

Patients with advanced HIV disease or patients with an impaired immunity have reported resistance to Iqbavir 250mg Injection. If you are not responding to Iqbavir 250mg Injection, the possibility of drug resistance should be checked.

Hair loss is an uncommon side effect of Iqbavir 250mg Injection. It stops when the medicine is discontinued.